Remdesivir Gets Full FDA Approval as Coronavirus Treatment
By News
Published 4 years ago on
October 22, 2020
Share
[aggregation-styles]
The Hill
The Food and Drug Administration (FDA) has granted full approval to the antiviral drug remdesivir to treat COVID-19, manufacturer Gilead announced Thursday.
FDA initially granted emergency use authorization for remdesivir in May, which allowed doctors and hospitals to use the drug to treat hospitalized patients without a full approval.
It showed modest results in reducing the hospitalizations of patients with severe cases of COVID-19. Remdesivir is administered in a hospital setting through an IV.
Read More →
The Hill
The Food and Drug Administration (FDA) has granted full approval to the antiviral drug remdesivir to treat COVID-19, manufacturer Gilead announced Thursday.
FDA initially granted emergency use authorization for remdesivir in May, which allowed doctors and hospitals to use the drug to treat hospitalized patients without a full approval.
It showed modest results in reducing the hospitalizations of patients with severe cases of COVID-19. Remdesivir is administered in a hospital setting through an IV.
Read More →
RELATED TOPICS:
Categories
Latest
Videos
Politics /
11 hours ago
Tennessee Lawmakers Pass Bill Criminalizing Adults Assisting Minors in Gender-Affirming Care
Politics /
12 hours ago
Did Arias ‘Weaponize’ City Attorney’s Office by Requesting Documents from Smittcamp?
Economy /
12 hours ago
Google Parent Reports Another Quarter of Robust Growth, Rolls Out First-Ever Quarterly Dividend
Economy /
14 hours ago
